NEW YORK (GenomeWeb News) – Predictive Physiology & Medicine, a diagnostic startup based in Bloomington, Ind., will use a $2.3 million grant from the National Heart, Lung, and Blood Institute to develop a proteomics-based test aimed at assessing cardiovascular health, the company said yesterday.
 
PPM said it is developing a test that will analyze 500 molecules in a single blood sample to detect conditions such as heart disease, diabetes, and hypertension “earlier than other tests.”
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Seattle Times writes that pharmacogenomics testing can help choose medications that may work best for people with depression.

Researchers report that deleting one gene from butterflies affects their wing coloration patterns, according to the Washington Post.

In PNAS this week: genome sequencing of weevil symbionts, retinoid X receptor deletion in lung cancer metastasis, and more.

Sequencing could help combat foodborne illnesses, according to a blog post by Food and Drug Administration officials.